Sulfonamides
Key Points
- Sulfonamides are among the oldest broad-spectrum antimicrobials and are primarily bacteriostatic.
- They inhibit bacterial metabolic enzymes needed for folate-related growth processes.
- Common uses include urinary tract infection, otitis media, acute exacerbation of chronic bronchitis, and travel-associated diarrhea.
- Allergic and delayed hypersensitivity reactions are common; discontinue at first rash and escalate promptly.
- Encourage hydration to reduce crystalluria and renal complications.
- For trimethoprim-sulfamethoxazole, monitor for bleeding risk with warfarin and hypoglycemia with oral antidiabetic therapy.
- TMP-SMX is contraindicated with dofetilide and in infants younger than 2 months.
- Severe reactions include Stevens-Johnson syndrome/toxic epidermal necrolysis, fulminant hepatic necrosis, blood dyscrasias, and hyperkalemia.
Mechanism of Action
Sulfonamides competitively inhibit bacterial metabolic enzymes required for cellular function and replication, producing bacteriostatic growth suppression against susceptible gram-positive and gram-negative organisms.
Clinical Use
- Urinary tract infections.
- Otitis media.
- Acute exacerbations of chronic bronchitis.
- Traveler’s diarrhea.
Prototype medication in this source: trimethoprim-sulfamethoxazole (TMP-SMX).
Nursing Considerations
- Check for sulfonamide allergy history before first dose.
- Monitor closely for delayed hypersensitivity reactions and stop therapy at the first sign of rash.
- Confirm baseline CBC and renal/hepatic function before and during therapy in high-risk clients.
- Anticipate renal dose adjustment in kidney impairment.
- Administer oral TMP-SMX with 8 oz water and reinforce daily hydration to reduce crystalluria risk.
- Monitor urine output and assess for cloudy urine or crystal-related urinary changes.
- Do not administer TMP-SMX intramuscularly.
- Use caution with interaction-prone drugs (including dofetilide, oral antidiabetics, and anticoagulants such as warfarin).
- Monitor INR and signs of bleeding when concurrent anticoagulant therapy is present.
- Track infection response with WBC trend, fever trend, infection-site assessment, and available culture results.
Side Effects and Adverse Effects
- Common: nausea, vomiting, diarrhea, headache.
- Dermatologic: photosensitivity and rash.
- Severe dermatologic/hepatic: Stevens-Johnson syndrome or toxic epidermal necrolysis, fulminant hepatic necrosis.
- Renal: crystalluria, potential kidney stone formation, or reduced kidney function.
- Hematologic/electrolyte: blood dyscrasias, bruising or bleeding tendency, and hyperkalemia risk.
Health Teaching
- Complete the full prescribed course and avoid skipped doses.
- If a dose is missed, take it when remembered unless it is close to the next scheduled dose.
- Use sunscreen and protective clothing due to photosensitivity risk.
- Report rash, sore throat, fever, mouth sores, unusual bleeding, or bruising immediately.
- Report persistent GI symptoms or worsening infection findings promptly.
Related Concepts
- antibiotics - Broad antimicrobial framework and stewardship context.
- culture-and-sensitivity-testing-in-infection-management - Supports regimen refinement when susceptibility data return.
- drug-interactions - Anticoagulant and antidiabetic interaction safety.
- monobactams - Another antimicrobial class used in selected gram-negative infections.
Self-Check
- Which early finding requires immediate discontinuation of sulfonamide therapy?
- Why is hydration emphasized during TMP-SMX treatment?
- What lab and bedside monitoring priorities apply when TMP-SMX is combined with warfarin?